Zimmer Biomet Holdings Quick Ratio 2006-2018 | ZBH
Historical quick ratio values for Zimmer Biomet Holdings (ZBH) over the last 10 years.
| Zimmer Biomet Holdings Quick Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets - Inventory | Current Liabilities | Quick Ratio |
| 2018-12-31 | $2.17B | $2.40B | 0.91 |
| 2018-09-30 | $2.29B | $2.39B | 0.96 |
| 2018-06-30 | $2.32B | $1.85B | 1.25 |
| 2018-03-31 | $3.65B | $3.43B | 1.07 |
| 2017-12-31 | $2.50B | $3.07B | 0.81 |
| 2017-09-30 | $2.35B | $3.01B | 0.78 |
| 2017-06-30 | $2.40B | $3.00B | 0.80 |
| 2017-03-31 | $3.10B | $2.66B | 1.17 |
| 2016-12-31 | $2.70B | $2.38B | 1.14 |
| 2016-09-30 | $2.63B | $2.31B | 1.14 |
| 2016-06-30 | $3.09B | $2.10B | 1.47 |
| 2016-03-31 | $3.00B | $1.52B | 1.98 |
| 2015-12-31 | $3.60B | $1.62B | 2.23 |
| 2015-09-30 | $4.04B | $1.79B | 2.26 |
| 2015-06-30 | $4.31B | $2.16B | 1.99 |
| 2015-03-31 | $10.70B | $0.91B | 11.78 |
| 2014-12-31 | $3.12B | $1.02B | 3.05 |
| 2014-09-30 | $3.16B | $1.09B | 2.89 |
| 2014-06-30 | $3.08B | $0.95B | 3.24 |
| 2014-03-31 | $2.92B | $0.92B | 3.18 |
| 2013-12-31 | $3.12B | $1.03B | 3.03 |
| 2013-09-30 | $2.76B | $0.80B | 3.43 |
| 2013-06-30 | $2.54B | $0.80B | 3.16 |
| 2013-03-31 | $2.43B | $0.76B | 3.18 |
| 2012-12-31 | $2.71B | $0.87B | 3.13 |
| 2012-09-30 | $2.64B | $0.76B | 3.49 |
| 2012-06-30 | $2.52B | $0.68B | 3.69 |
| 2012-03-31 | $2.39B | $0.86B | 2.77 |
| 2011-12-31 | $2.35B | $0.87B | 2.71 |
| 2011-09-30 | $2.11B | $0.68B | 3.12 |
| 2011-06-30 | $2.13B | $0.68B | 3.14 |
| 2011-03-31 | $2.07B | $0.71B | 2.91 |
| 2010-12-31 | $2.07B | $0.70B | 2.95 |
| 2010-09-30 | $2.08B | $0.70B | 2.98 |
| 2010-06-30 | $2.10B | $0.60B | 3.49 |
| 2010-03-31 | $1.98B | $0.66B | 3.02 |
| 2009-12-31 | $1.83B | $0.69B | 2.64 |
| 2009-09-30 | $1.48B | $0.68B | 2.18 |
| 2009-06-30 | $1.35B | $0.67B | 2.01 |
| 2009-03-31 | $1.25B | $0.70B | 1.78 |
| 2008-12-31 | $1.25B | $0.77B | 1.62 |
| 2008-09-30 | $1.49B | $0.84B | 1.78 |
| 2008-06-30 | $1.41B | $0.81B | 1.74 |
| 2008-03-31 | $1.47B | $0.79B | 1.86 |
| 2007-12-31 | $1.36B | $0.75B | 1.81 |
| 2007-09-30 | $1.17B | $0.71B | 1.65 |
| 2007-06-30 | $1.27B | $0.64B | 1.97 |
| 2007-03-31 | $1.23B | $0.60B | 2.05 |
| 2006-12-31 | $1.11B | $0.63B | 1.76 |
| 2006-09-30 | $1.08B | $0.68B | 1.58 |
| 2006-06-30 | $1.19B | $0.63B | 1.88 |
| 2006-03-31 | $1.23B | $0.57B | 2.15 |
| 2005-12-31 | $0.99B | $0.61B | 1.63 |
| 2005-09-30 | $0.91B | $0.66B | 1.39 |
| 2005-06-30 | $0.92B | $0.61B | 1.51 |
| 2005-03-31 | $0.93B | $0.61B | 1.52 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $25.222B | $7.933B |
| Zimmer Biomet Holdings, Inc. is a musculoskeletal healthcare company. The company design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. Zimmer Biomet Holdings, Inc., formerly known as Zimmer Holdings, Inc., is based in Warsaw, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $132.164B | 26.13 |
| Medtronic (MDT) | Ireland | $123.923B | 18.53 |
| Stryker (SYK) | United States | $69.625B | 25.56 |
| Boston Scientific (BSX) | United States | $55.366B | 27.03 |
| Baxter (BAX) | United States | $39.075B | 24.08 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.659B | 0.00 |
| ResMed (RMD) | United States | $14.394B | 27.30 |
| Canopy Growth (CGC) | Canada | $11.042B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.100B | 51.79 |
| Aurora Cannabis (ACB) | Canada | $7.040B | 50.36 |
| Hill-Rom Holdings (HRC) | United States | $6.974B | 21.57 |
| Perrigo (PRGO) | Ireland | $6.650B | 10.09 |
| Insulet (PODD) | United States | $5.226B | 0.00 |
| ICU Medical (ICUI) | United States | $5.190B | 28.91 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $4.539B | 0.00 |
| Haemonetics (HAE) | United States | $4.489B | 39.82 |
| Agios Pharmaceuticals (AGIO) | United States | $3.462B | 0.00 |
| Hutchison China MediTech (HCM) | China | $3.417B | 0.00 |
| Neogen (NEOG) | United States | $3.281B | 50.39 |
| NuVasive (NUVA) | United States | $3.013B | 28.03 |
| National Vision Holdings (EYE) | United States | $2.624B | 50.75 |
| Quidel (QDEL) | United States | $2.581B | 23.28 |
| Aphria (APHA) | $2.402B | 106.67 | |
| NxStage Medical (NXTM) | United States | $1.954B | 0.00 |
| AtriCure (ATRC) | United States | $1.279B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.231B | 17.70 |
| VAREX IMAGING (VREX) | United States | $1.198B | 23.45 |
| Cardiovascular Systems (CSII) | United States | $1.170B | 840.00 |
| MacroGenics (MGNX) | United States | $0.923B | 0.00 |
| Cerus (CERS) | United States | $0.878B | 0.00 |
| PetIQ (PETQ) | United States | $0.837B | 21.68 |
| Surmodics (SRDX) | United States | $0.766B | 111.39 |
| Evolus (EOLS) | United States | $0.747B | 0.00 |
| NanoString Technologies (NSTG) | United States | $0.719B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.713B | 22.07 |
| Meridian Bioscience (VIVO) | United States | $0.704B | 20.98 |
| OraSure Technologies (OSUR) | United States | $0.703B | 31.03 |
| Omeros (OMER) | United States | $0.688B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.625B | 20.05 |
| Quanterix (QTRX) | United States | $0.505B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $0.492B | 24.18 |
| Owens & Minor (OMI) | United States | $0.479B | 5.42 |
| TG Therapeutics (TGTX) | United States | $0.395B | 0.00 |
| Insys Therapeutics (INSY) | United States | $0.368B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.334B | 21.65 |
| BioLife Solutions (BLFS) | United States | $0.299B | 404.00 |
| Neptune Technologies & Bioresources Inc (NEPT) | Canada | $0.293B | 0.00 |
| Bovie Medical (APYX) | United States | $0.279B | 0.00 |
| Vapotherm (VAPO) | United States | $0.276B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.262B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.242B | 0.00 |
| Zynex (ZYXI) | United States | $0.165B | 15.97 |
| Surface Oncology (SURF) | United States | $0.150B | 0.00 |
| Fonar (FONR) | United States | $0.143B | 7.65 |
| Chembio Diagnostics (CEMI) | United States | $0.119B | 0.00 |
| Chimerix (CMRX) | United States | $0.101B | 0.00 |
| United-Guardian (UG) | United States | $0.091B | 18.98 |
| Female Health (VERU) | United States | $0.084B | 0.00 |
| CAS Medical Systems (CASM) | United States | $0.070B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.063B | 17.33 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.062B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.056B | 0.00 |
| ImmuCell (ICCC) | United States | $0.038B | 0.00 |
| Neurotrope (NTRP) | United States | $0.034B | 0.00 |
| Senestech (SNES) | United States | $0.021B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.013B | 0.00 |
| InVivo Therapeutics Holdings (NVIV) | United States | $0.013B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.011B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.010B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.007B | 13.57 |
